Stress-induced cardiomyopathy (takotsubo syndrome) in a patient with primary hemochromatosis
https://doi.org/10.30629/0023-2149-2026-104-3-226-234
Abstract
Hemochromatosis is a disease associated with excess iron in the body. Primary (hereditary) hemochromatosis, occurs due to mutations in genes encoding iron metabolism proteins. Elevated serum iron concentrations can lead to iron accumulation in parenchymatous organs and tissues, especially in the liver, pancreas, heart, pituitary gland, and testicles, resulting in the development of fibrosis and failure of these organs. Diagnosis of hereditary hemochromatosis includes genetic testing, evaluation of serum iron metabolism parameters, and imaging data. The article describes a case of Takotsubo syndrome development in a patient with primary hemochromatosis. Takotsubo syndrome is characterized by transient regional systolic dysfunction, dilation and edema of the apical and/or middle segments of the left ventricle (LV), in the absence of coronary artery obstruction during coronary angiography. At the age of 49, an examination revealed an increase in ferritin, genetic testing revealed a homozygous mutation C282Y in the HFE gene, hereditary hemochromatosis was diagnosed, erythrocytapheresis was performed, and she is being monitored by a hematologist. At the age of 56, she was hospitalized with suspected acute coronary syndrome with ST segment elevation, an increase in troponin I levels to 1.8 ng/ml. Coronary angiography did not reveal any hemodynamically significant stenosis. Echocardiography revealed hypoand dyskinesis of the apical segments, a decrease in the LV ejection fraction to 45%. Dynamically, normalization of the troponin level, ECG, and restoration of LV function were noted. Takotsubo syndrome was diagnosed in a patient with primary hemochromatosis, the combination of which was not mentioned in previously published works.
About the Authors
E. V. ReznikRussian Federation
Elena V. Reznik — Doctor of Medical Sciences, Head of the Department of Propedeutics of Internal Diseases No. 2 of the Institute of Clinical Medicine N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russia, Cardiologist of the GBUZ “City Clinical Hospital No. 31” named after Academician G.M. Savelyeva of Healthcare Department of Moscow, cardiologist at the Center for Personalized Medicine “MEDSI on Michurinsky Prospekt”
Moscow
ResearcherIDN-6856-2016
M. H.E. Laouar
Russian Federation
Mohamed H.E. Laouar — postgraduate student of the Department of Propaedeutics
Moscow
R. V. Ponomarev
Russian Federation
Rodion V. Ponomarev — Candidate of Medical Sciences .Head of the Sector for the Study of Non-Tumor Diseases of the Blood System
Moscow
D. V. Ustyuzhanin
Russian Federation
Dmitry V. Ustyuzhanin — Candidate of Medical Sciences, Senior Researcher, Laboratory of Magnetic Resonance Imaging, Tomography Department
Moscow
A. D. Belyakova
Russian Federation
Albina D. Belyakova — specialist of the clinical research support department
Moscow
G. N. Golukhov
Russian Federation
Georgy N. Golukhov — Doctor of Medical Sciences, President of the State Budgetary Healthcare Institution City Clinical Hospital No. 31 named after Academician G.M. Savelyeva, Moscow Health Department, Deputy Chairman of the Public Council under the Moscow City Health Department
Moscow
References
1. Barton J.C., Parker C.J. HFE-Related Hemochromatosis. 2000 Apr 3 [updated 2024 Apr 11]. In: Adam M.P., Feldman J., Mirzaa G.M ., Pagon R.A., Wallace S.E., Amemiya A. editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993– 2024. DOI: 10.12775/JEHS.2025.80.58359
2. Malaeva E.G., Adamenko E.I., Zharskaya O.M., Gavrusev A.A., Kozich Zh.M. Multiple organ lesion in hemochromatosis. Health and Ecology Issues. 2022;19(1):139–144. (In Russ.). DOI: 10.51523/2708-6011.2022-19-1-18
3. Kirk P., Roughton M., Porter J.B., Walker J.M, Tanner M.A, Patel J., Wu D., Taylor J., Westwood M.A., Anderson L.J., Pennell D.J. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120:1961–8. DOI: 10.1161/CIRCULATIONAHA.109.874487
4. Pennell D., Carpenter J., Roughton M., Cabantchik Z. On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure. J. Cardiovasc. Magn. Reson. 2011;13:45. DOI: 10.1186/1532-429X-13-45
5. Baltzer N.S., Stanislaus S., Saunamäki K., Grøndahl C., Banner J., Jørgensen M.B. Can acute stress be fatal? A systematic cross-disciplinary review. Stress. 2019;22(3):286–294. DOI: 10.1080/10253890.2018.1561847
6. Tsuchihashi K., Ueshima K., Uchida T., Oh-mura N., Kimura К. et al. Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction: Angina Pectoris–Myocardial Infarction Investigations in Japan. J. Am. Coll. Cardiol. 2001;38:11–18. DOI: 10.1016/S0735-1097(01)01316-X
7. Lyon A.R., Bossone E., Schneider B. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2016;18(1):8– 27. DOI: 10.1002/ejhf.424
8. Heit J.A. Thrombophilia: clinical and laboratory assessment and management. In: Kitchens C.S., Konkle B.A., Kessler C.M. editors. Consultative hemostasis and thrombosis: third edition. Philadelphia: Elsevier Saunders. 2013:205–39. DOI: 10.1016/B978-1-4557-2296-9.00014-2
9. Reznik E.V., Laouar M.H.E., Voinova V.Yu., Golukhov G.N. Hemochromatosis and Heart Involvement. The Russian Archives of Internal Medicine. 2024;14(6):442–456. (In Russ.). DOI: 10.20514/2226-6704-2024-14-6-442-456
Review
For citations:
Reznik E.V., Laouar M.H., Ponomarev R.V., Ustyuzhanin D.V., Belyakova A.D., Golukhov G.N. Stress-induced cardiomyopathy (takotsubo syndrome) in a patient with primary hemochromatosis. Clinical Medicine (Russian Journal). 2026;104(3):226-234. (In Russ.) https://doi.org/10.30629/0023-2149-2026-104-3-226-234
JATS XML






























